← Evidence map

ArticleCancers2025

Early Predictive Markers and Histopathological Response to Neoadjuvant Endocrine Therapy in Postmenopausal Patients with HR+/HER2- Early Breast Cancer.

Aleksandra Konieczna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Early Predictive Markers and Histopathological Response to Neoadjuvant Endocrine Therapy in Postmenopausal Patients with HR+/HER2- Early Breast Cancer. | OpenQuestion